Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
ALCOX:EPA
NicOx SA
€0.41
0.00%
(0.00) 1D
Apr 24, 5:35:26 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALCOX...
Open
€0.40
High
€0.41
Low
€0.40
Mkt. cap
33.20M
Avg. vol.
294.13K
Volume
78.79K
52-wk high
€0.65
52-wk low
€0.21
EPS
-€0.37
Shares outstanding
88.44M
No. of employees
5
News stories
From sources across the web
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi. Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees5
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
-
13.70M
763.05K
763.05K
Cost of goods sold
-
-
2.90M
2.90M
Cost of revenue
-
-
2.90M
2.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
421.39K
421.39K
Operating expense
-
-
441.99K
441.99K
Total operating expenses
-
-
3.34M
3.34M
Operating income
-
-
-2.58M
-2.58M
Other non operating income
-
-
-1.50M
-1.50M
EBT including unusual items
-
-
-4.47M
-4.47M
EBT excluding unusual items
-
-
-4.47M
-4.47M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
18.06K
18.06K
Net income
-
-
-4.47M
-4.47M
Net profit margin
-
-
-586.37%
-586.37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
186.72K
186.72K
Interest expense
-
-
-273.18K
-273.18K
Net interest expenses
-
-
-86.46K
-86.46K
Depreciation and amortization charges
-
-
2.54K
2.54K
EBITDA
-
-
-2.57M
-2.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more